Track topics on Twitter Track topics that are important to you
23andMe is teaming up with Spanish drugmaker Almirall to develop an antibody that treats certain inflammatory diseases using customer data.
The post 23andMe Working on New Drug Based on Users’ Genetics appeared first on Investing News Network.
Original Article: 23andMe Working on New Drug Based on Users’ GeneticsNEXT ARTICLE
An antibody is a protein produced by the body's immune system when it detects harmful substances, called antigens. Examples of antigens include microorganisms (such as bacteria, fungi, parasites, and viruses) and chemicals. Antibodies may be produc...